000 01465 a2200433 4500
005 20250518003316.0
264 0 _c20181030
008 201810s 0 0 eng d
022 _a1536-5964
024 7 _a10.1097/MD.0000000000012908
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDing, Wu
245 0 0 _aAnthracycline versus nonanthracycline adjuvant therapy for early breast cancer: A systematic review and meta-analysis.
_h[electronic resource]
260 _bMedicine
_cOct 2018
300 _ae12908 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnthracyclines
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
_xmethods
650 0 4 _aCyclophosphamide
_xtherapeutic use
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aTaxoids
_xtherapeutic use
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aLi, Zhian
700 1 _aWang, Caiyun
700 1 _aDai, Jiangfeng
700 1 _aRuan, GuoDong
700 1 _aTu, Chuanjian
773 0 _tMedicine
_gvol. 97
_gno. 42
_gp. e12908
856 4 0 _uhttps://doi.org/10.1097/MD.0000000000012908
_zAvailable from publisher's website
999 _c28952783
_d28952783